Advancing our understanding of AnkRD1 in cardiac development and disease.

Nathaniel P Murphy, Ellen R Lubbers, Peter J Mohler
Author Information
  1. Nathaniel P Murphy: Frick Center for Heart Failure and Arrhythmia Research and Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH, USA.
  2. Ellen R Lubbers: Frick Center for Heart Failure and Arrhythmia Research and Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH, USA.
  3. Peter J Mohler: Departments of Physiology and Cell Biology and Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Abstract

No abstract text available.

References

  1. PLoS One. 2014 Aug 04;9(8):e104040 [PMID: 25089522]
  2. Cardiovasc Res. 2015 May 1;106(2):261-71 [PMID: 25770146]
  3. Int J Mol Sci. 2017 Jun 26;18(7): [PMID: 28672880]
  4. Heliyon. 2018 Feb 01;4(1):e00514 [PMID: 29560432]
  5. PLoS One. 2012;7(12):e50436 [PMID: 23227174]
  6. J Am Coll Cardiol. 2009 Jul 21;54(4):325-33 [PMID: 19608030]
  7. Am J Pathol. 2015 Jan;185(1):96-109 [PMID: 25452119]
  8. J Gene Med. 2019 Apr;21(4):e3070 [PMID: 30659708]
  9. Biomed Res Int. 2015;2015:273936 [PMID: 25961010]
  10. Eur J Heart Fail. 2009 Jun;11(6):559-66 [PMID: 19359327]
  11. Cardiovasc Res. 2020 Jul 1;116(8):1458-1472 [PMID: 31688894]

Grants

  1. F30 HL137331/NHLBI NIH HHS
  2. R01 HL134824/NHLBI NIH HHS

MeSH Term

Heart
Muscle Proteins
Nuclear Proteins

Chemicals

Muscle Proteins
Nuclear Proteins